Moreover, the IL-12-augmented IFN-γ upregulates the expression of major histocompatibility class I and II proteins (MHC-I/MHC-II) on antigen-presenting cells, thereby improving the tumor antigen presentation for recognition by T lymphocytes31. Here, IFNG is linked to neoplasm.